pulsed field ablation

8 · 20 / page

Ask MedXY AI

Latest news

Tag

MedTechBoston ScientificWatchman

Boston Scientific Cuts 2026 Guidance Again as Watchman, Electrophysiology Businesses Struggle

By MedXY|Jul 29, 2026

Boston Scientific slashed its 2026 sales and EPS forecasts for the second straight quarter, citing competitive pressure in pulsed field ablation and declining standalone Watchman procedures.

Pulsed Field Ablation Versus Sham Procedure in Atrial Fibrillation: Insights from the PFA-SHAM Randomized Clinical Trial

Cardiologyatrial fibrillationpulsed field ablation

pulsed field ablation

Latest news

Boston Scientific Cuts 2026 Guidance Again as Watchman, Electrophysiology Businesses Struggle

Pulsed Field Ablation Versus Sham Procedure in Atrial Fibrillation: Insights from the PFA-SHAM Randomized Clinical Trial

High-Repetition-Frequency Nanosecond Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: 12-Month Outcomes From the SCENA-AF Trial

High-Voltage Focal Pulsed Field Ablation Achieves Transmurality and 98% Reduction in Scar-Related Ventricular Tachycardia

Nanosecond Pulsed Field Ablation Matches Radiofrequency Efficacy While Slashing Procedure Time: Insights From the InsightPFA Trial

Pulsed Field Ablation Demonstrates Exceptional Safety in Real-World Practice: Insights from the 40,000-Patient MANIFEST-US Study

ADVANTAGE AF Phase 2: Evaluating Pulsed Field Ablation for Persistent Atrial Fibrillation Using Continuous ECG Monitoring

Optimizing Sedation for Pulsed-Field Ablation in Atrial Fibrillation: Results of the COOPERATIVE-PFA Trial